ramosetron has been researched along with Irritable Bowel Syndrome in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (36.36) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, NM; Brady, CA; Butler, AS; Choo, SH; Cioffi, CL; Cohen, ML; Dobritsa, S; Earley, WG; Fitzpatrick, K; Guo, C; Guzzo, PR; Hassler, C; Manning, DD; Masih, L; Naginskaya, J; Ryan, KN; Sikkander, MI; Usyatinsky, A; Wierschke, JD; Zhang, Z | 1 |
| Chen, F; Li, Y; Qi, Q; Zhang, Y; Zuo, X | 1 |
| Barbara, G; Barbaro, MR; De Ponti, F; Dothel, G; Raschi, E | 1 |
| Akiho, H; Fukudo, S; Ida, M; Matsueda, K; Nakashima, Y | 1 |
| Camilleri, M; Grover, M | 1 |
| Hirata, T; Keto, Y; Nakata-Fukuda, M; Uchiyama, Y; Yamano, M; Yokoyama, T | 1 |
| Haruma, K; Hata, J; Imamura, H; Ishii, M; Kamada, T; Kusunoki, H; Manabe, N; Merchant, JL; Shiotani, A | 1 |
| Akiho, H; Fukudo, S; Haruma, K; Ida, M; Kinoshita, Y; Nakashima, Y; Nishida, A; Okumura, T | 1 |
| Akiho, H; Fukudo, S; Haruma, K; Hayashi, K; Ida, M; Kinoshita, Y; Nakashima, Y; Okumura, T | 1 |
| Morgan, B | 1 |
| Akiho, H; Fukudo, S; Haruma, K; Hayase, H; Hongo, M; Ida, M; Matsueda, K; Nakashima, Y | 1 |
| Harasawa, S; Hiwatashi, N; Hongo, M; Matsueda, K; Sasaki, D | 2 |
| Akiho, H; Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Miyata, K; Nishida, A; Sasamata, M | 1 |
| Bak, YT; Choi, MK; Choi, SC; Huh, KC; Kim, NY; Kwon, JK; Lee, JS; Lee, KJ; Lee, OY; Myung, SJ; Park, HJ; Rhee, PL; Sohn, CI | 1 |
| Clavé, P | 1 |
| Hirata, T; Keto, Y; Seki, N; Sengoku, T; Yamano, M; Yokoyama, T | 1 |
| Funatsu, T; Hirata, T; Keto, Y; Nakata, M; Sasamata, M | 1 |
| Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Sasamata, M | 1 |
| Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Sasamata, M; Takeuchi, A | 1 |
| Akuzawa, S; Funatsu, T; Hirata, T; Keto, Y; Miyata, K; Sasamata, M | 1 |
| den Adel, M; Kadokura, T; Krauwinkel, WJ; Nishida, A; Takeshige, T | 1 |
4 review(s) available for ramosetron and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Ramosetron for the treatment of irritable bowel syndrome with diarrhea: a systematic review and meta-analysis of randomized controlled trials.
Topics: Abdominal Pain; Benzimidazoles; Constipation; Diarrhea; Humans; Irritable Bowel Syndrome; Serotonin 5-HT3 Receptor Antagonists | 2018 |
Advancements in drug development for diarrhea-predominant irritable bowel syndrome.
Topics: Animals; Benzimidazoles; Diarrhea; Drug and Narcotic Control; Drug Design; Gastrointestinal Agents; Humans; Imidazoles; Internationality; Irritable Bowel Syndrome; Phenylalanine | 2018 |
[Pharmacological and clinical profile of ramosetron hydrochloride (Irribow), a novel therapeutic agent for irritable bowel syndrome with diarrhea].
Topics: Animals; Benzimidazoles; Clinical Trials as Topic; Diarrhea; Dose-Response Relationship, Drug; Humans; Irritable Bowel Syndrome; Randomized Controlled Trials as Topic; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Stress, Psychological | 2009 |
Pharmacological profile of ramosetron, a novel therapeutic agent for IBS.
Topics: Abdominal Pain; Animals; Benzimidazoles; Defecation; Diarrhea; Dogs; Gastrointestinal Transit; Humans; Irritable Bowel Syndrome; Mice; Models, Animal; Rats; Serotonin Antagonists | 2007 |
7 trial(s) available for ramosetron and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea.
Topics: Administration, Oral; Adult; Animals; Benzimidazoles; Chemical Phenomena; Diarrhea; Double-Blind Method; Feces; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Japan; Male; Middle Aged; Placebos; Rats; Treatment Outcome; Young Adult | 2014 |
Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women.
Topics: Adult; Benzimidazoles; Constipation; Diarrhea; Female; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Japan; Middle Aged; Prospective Studies; Quality of Life; Risk Factors; Serotonin 5-HT3 Receptor Antagonists; Sex Factors; Time Factors; Treatment Outcome; Young Adult | 2016 |
Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study.
Topics: Adult; Benzimidazoles; Diarrhea; Drug Administration Schedule; Female; Humans; Irritable Bowel Syndrome; Middle Aged; Serotonin Antagonists; Treatment Outcome | 2016 |
Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo-controlled phase II study.
Topics: Abdominal Pain; Adult; Benzimidazoles; Diarrhea; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Middle Aged; Serotonin Antagonists; Treatment Outcome | 2017 |
A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.
Topics: Adult; Benzimidazoles; Diarrhea; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Japan; Male; Middle Aged; Serotonin Antagonists; Treatment Outcome | 2008 |
A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome.
Topics: Adult; Asian People; Benzimidazoles; Double-Blind Method; Female; Humans; Irritable Bowel Syndrome; Japan; Male; Serotonin Antagonists; Treatment Outcome | 2008 |
Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
Topics: Adolescent; Adult; Benzimidazoles; Diarrhea; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Parasympatholytics; Phenethylamines; Republic of Korea; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Young Adult | 2011 |
11 other study(ies) available for ramosetron and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.
Topics: Animals; Cell Line; Disease Models, Animal; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Mice; Microsomes, Liver; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists | 2011 |
Ramosetron in irritable bowel syndrome with diarrhea: new hope or the same old story?
Topics: Animals; Benzimidazoles; Chemical Phenomena; Diarrhea; Feces; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Male | 2014 |
Inhibitory effect of the selective serotonin 5-HT₃ receptor antagonist ramosetron on duodenal acidification-induced gastric hypersensitivity in rats.
Topics: Animals; Benzimidazoles; Biguanides; Duodenum; Hydrogen-Ion Concentration; Irritable Bowel Syndrome; Male; Nociception; Quinolizines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT3 Receptor Antagonists; Stomach | 2014 |
Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1.
Topics: Adult; Annexin A2; Benzimidazoles; Biomarkers, Pharmacological; Diarrhea; Female; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Middle Aged; Pilot Projects; Polymorphism, Single Nucleotide; S100 Proteins; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Tryptophan Hydroxylase | 2015 |
Drug development: A healthy pipeline.
Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; Colestipol; Disease Models, Animal; Enteric Nervous System; Female; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Male; Mice; Natriuretic Peptides; Peptides; Phenylalanine; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Rifamycins; Rifaximin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Visceral Pain | 2016 |
Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.
Topics: Benzimidazoles; Diarrhea; Humans; Irritable Bowel Syndrome; Male; Parasympatholytics; Phenethylamines; Serotonin 5-HT3 Receptor Antagonists | 2011 |
Inhibitory effect of ramosetron on corticotropin releasing factor- and soybean oil-induced delays in gastric emptying in rats.
Topics: Animals; Antidiarrheals; Benzamides; Benzimidazoles; Benzyl Compounds; Biguanides; Corticotropin-Releasing Hormone; Dyspepsia; Fenclonine; Gastric Emptying; Irritable Bowel Syndrome; Male; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Soybean Oil | 2012 |
Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
Topics: Animals; Benzimidazoles; Carbazoles; Carbolines; Carrier Proteins; Colon; Defecation; Gastrointestinal Agents; Guinea Pigs; Humans; Ion Channels; Irritable Bowel Syndrome; Loperamide; Male; Muscle, Smooth; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Restraint, Physical; Serotonin Antagonists; Stress, Psychological | 2007 |
Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
Topics: Animals; Behavior, Animal; Benzimidazoles; Carbazoles; Carbolines; Colon; Colonic Diseases, Functional; Conditioning, Psychological; Corticotropin-Releasing Hormone; Defecation; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Gastrointestinal Transit; Immobilization; Irritable Bowel Syndrome; Loperamide; Male; Peptide Fragments; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Stress, Psychological; Time Factors; Treatment Outcome | 2007 |
Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
Topics: Animals; Antidiarrheals; Benzimidazoles; Conditioning, Classical; Defecation; Fear; Irritable Bowel Syndrome; Loperamide; Male; Parasympatholytics; Quinolizines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Stress, Physiological; Trimebutine | 2008 |
The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects.
Topics: Adult; Area Under Curve; Benzimidazoles; Cross-Over Studies; Drug Interactions; Female; Fluvoxamine; Half-Life; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2008 |